Pseudoprogression and improvement of quality of life in a patient with advanced endometrial cancer treated with immunotherapy: a case report

Pseudoprogression and improvement of quality of life in a patient with advanced endometrial cancer treated with immunotherapy: a case report

Until recently, treatment options for patients with recurrent or metastatic endometrial cancer (EC) were limited. First-line treatment is usually based on carboplatin and paclitaxel and there was no standard second- line therapy following platinum failure. However, the introduction of immunotherapy...

Full description

Saved in:
Bibliographic Details
Main Authors: Valentina Tuninetti, Roberta Danese, Amedeo Calvo, Marco Bellero, Lavinia Bianco, Valentina Ariu, Maria Grazia Ruo Redda, Paola Campisi, Alessandra Bianco, Giovanni De Rosa, Massimo Petracchini, Giorgio Valabrega
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2025-06-01
Series:Drugs in Context
Subjects:
dostarlimab
endometrial cancer
immunotherapy
quality of life
pseudoprogression
Online Access:https://www.drugsincontext.com/pseudoprogression-and-improvement-of-quality-of-life-in-a-patient-with-advanced-endometrial-cancer-treated-with-immunotherapy-a-case-report/
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.drugsincontext.com/pseudoprogression-and-improvement-of-quality-of-life-in-a-patient-with-advanced-endometrial-cancer-treated-with-immunotherapy-a-case-report/

Similar Items